Delivery Order SPE2DB20D3103-SPE2DB26FL4X3
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $20,474.63 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCtz 320-25 mg tablets (90-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. The contract employs firm fixed pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, with...
- The Defense Logistics Agency awarded a delivery order valued at $2,206.20 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCtz 320-25 mg tablets (90-count units). This competitive award, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, reflects a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count packaging). The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price terms with no set-aside designation. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $1,431.45 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90 count), with completion scheduled for October 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed from the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,913.12 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90 count) with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,531.30 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCT 160-12.5 mg tablets (90-count) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves...
- The Defense Logistics Agency awarded a $3,084.13 delivery order to AmerisourceBergen Drug Corp for Valsartan-HCT 320-25 mg tablets (90-count units) with an ultimate completion date of June 3, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a contract ceiling value of $11,676.65. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4X3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,664.45 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) on November 4, 2025, with completion expected by November 5, 2025. This competitively awarded, non-set-aside contract features firm fixed pricing and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare needs through its extensive contract portfolio with the Defense Logistics Agency. The company's federal awards demonstrate capability across a broad spectrum of pharmaceutical products, including generic and brand-name medications, vaccines, and specialized medical supplies. This particular delivery order for Valsartan-HCZ, an antihypertensive medication, represents routine pharmaceutical fulfillment under the company's prime vendor relationship with DLA Troop Support, which enables flexible sourcing of medications to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/4/25 |